Richard T Piszczatowski

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 7

Top Topics

Monoclonal Antibody

Top Venues

The Journal of experimental medicine

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Richard T Piszczatowski, Hannes E Bülow, Ulrich Steidl
Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis. Blood 143 (25) (2024)
Richard T Piszczatowski, Hannes E Bülow, Ulrich Steidl
Heparan Sulfates and Heparan Sulfate Proteoglycans in Hematopoiesis. Blood (2024)
Richard T Piszczatowski, Hannes E Bülow, Ulrich Steidl
Heparan sulfates and heparan sulfate proteoglycans in hematopoiesis. Blood 143 (25) (2024)
Richard T Piszczatowski, Hannes E Bülow, Ulrich Steidl
Heparan Sulfates and Heparan Sulfate Proteoglycans in Hematopoiesis. Blood (2024)
Richard T Piszczatowski, Emily Schwenger, Sriram Sundaravel, Catarina M Stein, Yang Liu, Pamela Stanley, Amit K Verma, Deyou Zheng, Ronald D Seidel, Steven C Almo, Robert A Townley, Hannes E Bülow, Ulrich Steidl
A glycan-based approach to cell characterization and isolation: Hematopoiesis as a paradigm. The Journal of experimental medicine 219 (11) (2022)
Richard T Piszczatowski, Ulrich Steidl
Aurora Kinase A Inhibition: A Mega-Hit for Myelofibrosis Therapy? Clinical cancer research : an official journal of the American Association for Cancer Research 25 (16) (2019)
Robert F Stanley, Richard T Piszczatowski, Boris Bartholdy, Kelly Mitchell, Wendy M McKimpson, Swathi Narayanagari, Dagmar Walter, Tihomira I Todorova, Cassandra M Hirsch, Hideki Makishima, Britta Will, Christine McMahon, Kira Gritsman, Jaroslaw P Maciejewski, Richard N Kitsis, Ulrich Steidl
A myeloid tumor suppressor role for NOL3. The Journal of experimental medicine 214 (3) (2017)